Institutional investors purchased a net $1.7 million shares of DEPO during the quarter ended September 2016 and now own 100.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LITESPEED MANAGEMENT LLC Bought 1.2 Million shares of Depomed Inc
SENVEST MANAGEMENT LLC Bought 1.1 Million shares of Depomed Inc
BLACKROCK FUND ADVISORS Bought 771.3 Thousand shares of Depomed Inc